NeoGenomics Inc (NEO)
Quick ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 367,012 | 342,488 | 263,180 | 316,827 | 228,713 |
| Short-term investments | US$ in thousands | 19,832 | 72,715 | 174,809 | 198,563 | 67,546 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 301,241 | 96,304 | 89,932 | 87,232 | 73,183 |
| Quick ratio | 1.28 | 4.31 | 4.87 | 5.91 | 4.05 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($367,012K
+ $19,832K
+ $—K)
÷ $301,241K
= 1.28
The quick ratio for NeoGenomics Inc has shown variability over the years. In December 2020, the quick ratio was 4.05, indicating a strong liquidity position. This ratio increased significantly to 5.91 by December 2021, suggesting an even healthier liquidity position. However, in December 2022, the quick ratio decreased to 4.87, still indicating good liquidity but slightly lower than the previous year.
By December 2023, the quick ratio further decreased to 4.31, which suggests a slight deterioration in the company's ability to meet its short-term obligations with its most liquid assets. The most recent data in December 2024 shows a significant decline in the quick ratio to 1.28, indicating a potential liquidity concern as the company may face difficulty in meeting its short-term obligations with its current liquid assets.
Overall, while the quick ratio for NeoGenomics Inc has been relatively strong in the past years, the recent downward trend raises some concerns about the company's liquidity position and ability to cover its short-term liabilities. Management may need to closely monitor this ratio and take appropriate measures to improve liquidity in the future.